Patent: 9,492,417
✉ Email this page to a colleague
Summary for Patent: 9,492,417
Title: | Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer |
Abstract: | The present disclosure relates to the discovery that compounds of the invention, particularly 3-bromopyruvate and related compounds, can be safely administered at concentrations effective for the treatment of cancer when formulated with an acidity of greater than or equal to pH of 2 and less than or equal to a pH of 6. Disclosed herein are novel and improved methods and compositions for the treatment of cancer using 3-halopyruvate and related compounds. |
Inventor(s): | Geschwind; Jean-Francois (Potomac, MD), Vali; Mustafa (Baltimore, MD) |
Assignee: | The Johns Hopkins University (Baltimore, MD) |
Application Number: | 12/583,598 |
Patent Claims: | see list of patent claims |
Details for Patent 9,492,417
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2028-08-21 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |